Earnshaw SR, Graham CN, Ettinger B, Amonkar MM, Lynch NO, Middelhoven H. Cost-effectiveness of bisphosphonate therapies for women with postmenopausal osteoporosis: implications of improved persistence with less frequently administered oral bisphosphonates. Curr Med Res Opin. 2007 Oct 1;23(10):2517-29.
Greene BL, Brown TM, Harshman RS, Richerson GT, Turner BH, Skrepnek SH, Doyle JJ. Impact of the BP DownShift Program on blood pressure control among commercial driver license employees with diabetes and obesity. Poster presented at the 67th Scientific Sessions of the American Diabetes Association; June 2007. [abstract] Diabetes. 2007 Jun; 56(Suppl 1):A500.
Yood MU, Lafata JE, Koro C, Wells KE, Pladevall-Vila M. Time to pharmacotherapy change in response to elevated HbA(1c) test results. Curr Med Res Opin. 2006 Aug;22(8):1567-74.
Philip S, Fleming A, Goatman K, Sharp P, Olson J. Automated image quality assessment is an essential step for automating diabetic retinopathy detection. Poster presented at the 66th Scientific Session; June 9, 2006. Washington, DC. [abstract] Diabetes. 2006 Jun 9; 55(supplement 1):A513.
Portenoy R, ID Pain Steering Committee, McLeod LD. Development and testing of a neuropathic pain screening questionnaire: ID Pain. Curr Med Res Opin. 2006;22(8):1555-65.
Flavell DM, Ireland H, Stephens JW, Hawe E, Acharya J, Mather H, Hurel SJ, Humphries SE. Peroxisome proliferator-activated receptor alpha gene variation influences age of onset and progression of type 2 diabetes. Diabetes. 2005;54(2):582-6.
Mladsi DM, Grogg AL, Irish WD, Lopez RB, Degen K, Swann A, Nimsch CT. Pharmacy cost evaluation of risperidone, olanzapine, and quetiapine for the treatment of schizophrenia in acute care inpatient settings. Curr Med Res Opin. 2004 Jan 1;20(12):1883-93. doi: 10.1185/030079904X11510.
Wagner JD, Welles EG, Bell-Farrow AD, Anthony MS, Cefalu WT. Non-ketotic hyperglycemia and obesity preceding insulinopenic state in aged monkeys (macaca fascicularis). Diabetes. 1991;40(Suppl 40):219A.